Latest Health & pharmaceuticals news

2nd May
Gilead’s Remdesivir gets emergency use authorization from the FDA to treat COVID-19
1st May
Clorox’s quarterly sales surge 15% as Coronavirus fuels demand for cleaning products
1st May
Amgen says it will test Otezla for COVID-19 as it posts an upbeat Q1 earnings report
29th April
General Electric posts an 8% lower revenue in Q1 due to Coronavirus restrictions
28th April
Merck & Co. reports a 10% higher profit in Q1 on solid demand for its cancer drug
28th April
Pfizer jumps 2% in premarket trading on an upbeat financial report
27th April
Regeneron and Sanofi’s arthritis drug shows no benefit in non-critical COVID-19 patients
24th April
Sanofi notes upbeat sales and profit in Q1 on higher demand due to COVID-19
23rd April
Eli Lilly’s quarterly revenue jumps 15% as customers stockpile drugs ahead of COVID-19 restrictions
23rd April
AstraZeneca tests Farxiga as a possible treatment for COVID-19
22nd April
Biogen tanks 6% in premarket trading despite an upbeat financial report
17th April
BARDA awards £387 million to Moderna Inc. to ramp-up development of COVID-19 vaccine
17th April
Gilead Sciences jumps 16% as severe COVID-19 patients respond to its antiviral drug
16th April
Abbott Laboratories records a 16% lower profit in the first quarter
15th April
UnitedHealth climbs 2.6% on an upbeat earnings report
14th April
Johnson & Johnson beats analysts’ estimates for earnings and revenue in the first quarter
13th April
SCWorx climbs over 500% as it receives an order for 48 million COVID-19 rapid testing kits
11th April
Johnson & Johnson suspends plans of buying Takeda Pharmaceutical’s TachoSil
10th April
Pfizer identifies an antiviral drug as a potential treatment of Coronavirus
7th April
Eli Lilly cuts insulin-related out of pocket expense for diabetes patients in the U.S
5th April
Gilead Speeds Up Production of Experimental COVID-19 Drug, Stock Up 7%
2nd April
Walgreens Boots Alliance beats analysts’ estimates for earnings and revenue in the second quarter
31st March
3M to double its production of N95 respirators to meet the sharply rising demand
30th March
Johnson & Johnson Stock Price Surges 7% On a $450 Million Coronavirus Vaccine Contract
30th March
J&J to begin human trials of its experimental Coronavirus drug by September
1 2 3 4 5 6 7 8 9 10 11 12 13 57
Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.